On ECHEMI
Home > Drugs > Gansu Lanyao Pharmaceutical Co., Ltd.
Gansu Lanyao Pharmaceutical Co., Ltd.
  • Founded in:

    2006-12-22
  • Country:

    China China
  • Address:

    No. 1739, Middle Section of Kunlunshan Avenue, Lanzhou New District, Lanzhou City, Gansu Province
  • Tax NO.:

    916200007948829218
  • Registered Funds:

    84.5 million yuan
  • Email:

Related Drugs
Ethamethamide injection
Phenolsulfonylamine, chemical name: 2,5-dihydroxybenzenesulfonic acid diethylamine salt
Name Description Content CAS NO. Registered Holders
Etamsylate

It can cause blood vessels to contract, reduce capillary permeability, enhance platelet aggregation and adhesion, promote platelets to release coagulation active substances, shorten coagulation time, and achieve hemostatic effect.

More

It can cause blood vessels to contract, reduce capillary permeability, enhance platelet aggregation and adhesion, promote platelets to release coagulation active substances, shorten coagulation time, and achieve hemostatic effect.

2624-44-4 11
Piracetam Capsules
The main ingredient of this product: Piroxicam.
Name Description Content CAS NO. Registered Holders
Piroxicam

It is a similar substance of aminobutyric acid, which can activate, protect and repair brain cells, improve brain hypoxia, activate brain cells, increase the ATP/ADP ratio in the brain, promote the absorption of amino acids and phospholipids, protein synthesis, glucose utilization and energy storage, promote brain metabolism, increase cerebral blood flow. It can accelerate the speed of information transmission between the cerebral hemispheres through the corpus callosum, and improve the ability of learning, memory and thinking activities.

More

It is a similar substance of aminobutyric acid, which can activate, protect and repair brain cells, improve brain hypoxia, activate brain cells, increase the ATP/ADP ratio in the brain, promote the absorption of amino acids and phospholipids, protein synthesis, glucose utilization and energy storage, promote brain metabolism, increase cerebral blood flow. It can accelerate the speed of information transmission between the cerebral hemispheres through the corpus callosum, and improve the ability of learning, memory and thinking activities.

36322-90-4 33
Gentamycin Sulfate Injection
The main ingredient of this product is gentamicin sulfate, which is a multi-component antibiotic containing components such as C1, C1a, C2a, and C2.
Name Description Content CAS NO. Registered Holders
Gentamicin sulfate

This product is an aminoglycoside antibiotic. It has good antibacterial effects on various Gram-negative and Gram-positive bacteria, and has good antibacterial effects on various Enterobacteriaceae such as Escherichia coli, Klebsiella, Proteus, Salmonella, Shigella, Enterobacter, Serratia and Pseudomonas aeruginosa. Neisseria and Haemophilus influenzae are moderately sensitive to this product. It also has a certain effect on Brucella, Yersinia pestis, Acinetobacter and Campylobacter fetus. It has a good antibacterial effect on about 80% of methicillin-sensitive strains of Staphylococcus (including Staphylococcus aureus and coagulase-negative Staphylococci), but methicillin-resistant strains are mostly resistant to this product. It has a poor effect on Streptococcus and Streptococcus pneumoniae, and Enterococcus is mostly resistant to this product. When this product is used in combination with beta-lactams, most of them can obtain a synergistic antibacterial effect. The mechanism of action of this product is to bind to the 30S subunit of bacterial ribosomes and inhibit the synthesis of bacterial proteins. In recent years, the number of gram-negative bacteria resistant to gentamicin has increased significantly.

More

This product is an aminoglycoside antibiotic. It has good antibacterial effects on various Gram-negative and Gram-positive bacteria, and has good antibacterial effects on various Enterobacteriaceae such as Escherichia coli, Klebsiella, Proteus, Salmonella, Shigella, Enterobacter, Serratia and Pseudomonas aeruginosa. Neisseria and Haemophilus influenzae are moderately sensitive to this product. It also has a certain effect on Brucella, Yersinia pestis, Acinetobacter and Campylobacter fetus. It has a good antibacterial effect on about 80% of methicillin-sensitive strains of Staphylococcus (including Staphylococcus aureus and coagulase-negative Staphylococci), but methicillin-resistant strains are mostly resistant to this product. It has a poor effect on Streptococcus and Streptococcus pneumoniae, and Enterococcus is mostly resistant to this product. When this product is used in combination with beta-lactams, most of them can obtain a synergistic antibacterial effect. The mechanism of action of this product is to bind to the 30S subunit of bacterial ribosomes and inhibit the synthesis of bacterial proteins. In recent years, the number of gram-negative bacteria resistant to gentamicin has increased significantly.

1405-41-0 29
Gentamycin Sulfate Injection
The main ingredient of this product is gentamicin sulfate, which is a multi-component antibiotic containing components such as C1, C1a, C2a, and C2.
Name Description Content CAS NO. Registered Holders
Gentamicin sulfate

This product is an aminoglycoside antibiotic, which has good antibacterial effect on various Gram-negative bacteria and Gram-positive bacteria. Its mechanism of action is to bind to the 30S subunit of bacterial ribosomes and inhibit the synthesis of bacterial proteins.

More

This product is an aminoglycoside antibiotic, which has good antibacterial effect on various Gram-negative bacteria and Gram-positive bacteria. Its mechanism of action is to bind to the 30S subunit of bacterial ribosomes and inhibit the synthesis of bacterial proteins.

1405-41-0 29
Ribavirin Tablets
Ribavirin
Name Description Content CAS NO. Registered Holders
Ribavirin

A broad-spectrum antiviral drug that inhibits the growth of multiple viruses; it acts as a competitive inhibitor of viral synthetase through its phosphorylation product, reducing intracellular guanosine triphosphate and impairing viral RNA and protein synthesis; it may have an immune effect and neutralizing antibody effect on respiratory syncytial virus.

More

A broad-spectrum antiviral drug that inhibits the growth of multiple viruses; it acts as a competitive inhibitor of viral synthetase through its phosphorylation product, reducing intracellular guanosine triphosphate and impairing viral RNA and protein synthesis; it may have an immune effect and neutralizing antibody effect on respiratory syncytial virus.

36791-04-5 33
Feedback & Suggestions
Send Message

Thank you for your feedback. If you require further assistance, please contact us by email at info@echemi.com or call us at +86-532-55729510.